Metformin monotherapy significantly decreases epicardial adirose tissue thickness in newly diagnosed type 2 diabetes patients

dc.contributor.author	Ziyrek, Murat
dc.contributor.author	Kahraman, Serkan
dc.contributor.author	Ozdemir, Emrah
dc.contributor.author	Dogan, All
dc.date.accessioned	2021-12-21T08:45:45Z
dc.date.available	2021-12-21T08:45:45Z
dc.date.issued	2019
dc.identifier.issn	0870-2551
dc.identifier.issn	0304-4750
dc.identifier.uri	https://doi.org/10.1016/j.repc.2018.08.010
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1751
dc.description.abstract	introduction: Imbalance between pro-and anti-inflammatory cytokines secreted from visceral adipose tissue (VAT) contributes to the pathogenesis of certain cardiovascular and metabolic disorders, including insulin resistance. Epicardial adipose tissue (EAT
dc.language.iso	English
dc.publisher	Elsevıer Espana Slu
dc.relation.ispartof	22nd Turkish National Cardiology Congress
dc.rights	gold
dc.title	Metformin monotherapy significantly decreases epicardial adirose tissue thickness in newly diagnosed type 2 diabetes patients
dc.type	Article; Proceedings Paper
dc.relation.journal	Revısta Portuguesa De Cardıologıa
dc.identifier.issue	6
dc.identifier.startpage	419
dc.identifier.endpage	423
dc.identifier.volume	38
dc.identifier.doi	10.1016/j.repc.2018.08.010
dc.relation.issue	6
dc.relation.volume	38